IpsiHand: Direct Re-coupling of Intention and Movement
Share:


Sam Fok, Raphael Schwartz, Mark Wronkiewicz, Charles Holmes, Jessica Zhang, Nathan Brodell, Thane Somers. Washington University in St. Louis, USA
Abstract
Stroke and traumatic brain injury (TBI) cause long-term, unilateral loss of motor control due to brain damage on the opposing (contralateral) side of the body. Conventional neurological therapies have been found ineffective in rehabilitating upper-limb function after stroke. Brain computer interfaces (BCIs), devices that tap directly into brain signals, show promise in providing rehabilitation but remain in research. Also, BCIs cannot work if the target signals have been eliminated due to injury. Therefore we present a novel BCI, the IpsiHand, which combines advances in neurophysiology, electronics, and rehabilitation. Recent studies show that during hand movement, the cortical hemisphere on the same (ipsilateral) side of the body as the hand also activates. IpsiHand uses electroencephalography (EEG) to record these signals and control a powered hand orthosis. The undamaged hemisphere can then control both hands, and through neural plasticity IpsiHand will strengthen ipsilateral neural pathways to enhance ipsilateral motor control.
Sam Fok, Raphael Schwartz, Mark Wronkiewicz, Charles Holmes, Jessica Zhang, Nathan Brodell, Thane Somers. Washington University in St. Louis, USA
Abstract
Stroke and traumatic brain injury (TBI) cause long-term, unilateral loss of motor control due to brain damage on the opposing (contralateral) side of the body. Conventional neurological therapies have been found ineffective in rehabilitating upper-limb function after stroke. Brain computer interfaces (BCIs), devices that tap directly into brain signals, show promise in providing rehabilitation but remain in research. Also, BCIs cannot work if the target signals have been eliminated due to injury. Therefore we present a novel BCI, the IpsiHand, which combines advances in neurophysiology, electronics, and rehabilitation. Recent studies show that during hand movement, the cortical hemisphere on the same (ipsilateral) side of the body as the hand also activates. IpsiHand uses electroencephalography (EEG) to record these signals and control a powered hand orthosis. The undamaged hemisphere can then control both hands, and through neural plasticity IpsiHand will strengthen ipsilateral neural pathways to enhance ipsilateral motor control.
Sam Fok, Raphael Schwartz, Mark Wronkiewicz, Charles Holmes, Jessica Zhang, Nathan Brodell, Thane Somers. Washington University in St. Louis, USA
Abstract
Stroke and traumatic brain injury (TBI) cause long-term, unilateral loss of motor control due to brain damage on the opposing (contralateral) side of the body. Conventional neurological therapies have been found ineffective in rehabilitating upper-limb function after stroke. Brain computer interfaces (BCIs), devices that tap directly into brain signals, show promise in providing rehabilitation but remain in research. Also, BCIs cannot work if the target signals have been eliminated due to injury. Therefore we present a novel BCI, the IpsiHand, which combines advances in neurophysiology, electronics, and rehabilitation. Recent studies show that during hand movement, the cortical hemisphere on the same (ipsilateral) side of the body as the hand also activates. IpsiHand uses electroencephalography (EEG) to record these signals and control a powered hand orthosis. The undamaged hemisphere can then control both hands, and through neural plasticity IpsiHand will strengthen ipsilateral neural pathways to enhance ipsilateral motor control.
Solutions
Support
Company

© 2025 EMOTIV, All rights reserved.

Your Privacy Choices (Cookie Settings)
*Disclaimer – EMOTIV products are intended to be used for research applications and personal use only. Our products are not sold as Medical Devices as defined in EU directive 93/42/EEC. Our products are not designed or intended to be used for diagnosis or treatment of disease.
Note on Translations: Non-English versions of this website has been translated for your convenience using artificial intelligence. While we strive for accuracy, automated translations may contain errors or nuances that differ from the original text. For the most accurate information, please refer to the English version of this site.
Solutions
Support
Company

© 2025 EMOTIV, All rights reserved.

Your Privacy Choices (Cookie Settings)
*Disclaimer – EMOTIV products are intended to be used for research applications and personal use only. Our products are not sold as Medical Devices as defined in EU directive 93/42/EEC. Our products are not designed or intended to be used for diagnosis or treatment of disease.
Note on Translations: Non-English versions of this website has been translated for your convenience using artificial intelligence. While we strive for accuracy, automated translations may contain errors or nuances that differ from the original text. For the most accurate information, please refer to the English version of this site.
Solutions
Support
Company

© 2025 EMOTIV, All rights reserved.

Your Privacy Choices (Cookie Settings)
*Disclaimer – EMOTIV products are intended to be used for research applications and personal use only. Our products are not sold as Medical Devices as defined in EU directive 93/42/EEC. Our products are not designed or intended to be used for diagnosis or treatment of disease.
Note on Translations: Non-English versions of this website has been translated for your convenience using artificial intelligence. While we strive for accuracy, automated translations may contain errors or nuances that differ from the original text. For the most accurate information, please refer to the English version of this site.